BAYER AG (BAYN.F) Financials
BAYN.F Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 116.3 billion | 83.2 billion |
| 2023-09-30 | 117.2 billion | 83.7 billion |
| 2023-06-30 | 121.7 billion | 84.5 billion |
| 2023-03-31 | 125.1 billion | 84.0 billion |
BAYN.F Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 4.6 billion | ? |
| 2023-09-30 | 1.9 billion | ? |
| 2023-06-30 | -122.0 million | ? |
| 2023-03-31 | -4.0 billion | ? |
BAYN.F Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 1.3 billion |
| 2023-09-30 | -4.6 billion |
| 2023-06-30 | -1.9 billion |
| 2023-03-31 | 2.2 billion |
BAYN.F Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 1.2 billion |
| 2023-09-30 | - | - | - |
| 2023-06-30 | - | - | - |
| 2023-03-31 | - | - | - |
BAYN.F Shares Outstanding
BAYN.F Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 996.0 million | 1.1 billion | 3.6 billion | - |
| 2023-09-30 | 683.0 million | 1.5 billion | 3.6 billion | - |
| 2023-06-30 | 606.0 million | 1.2 billion | 3.7 billion | - |
| 2023-03-31 | 606.0 million | 1.6 billion | 4.1 billion | - |
BAYN.F Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 11.9 billion | 4.5 billion |
| 2023-09-30 | 10.3 billion | 4.8 billion |
| 2023-06-30 | 11.0 billion | 4.7 billion |
| 2023-03-31 | 14.4 billion | 5.7 billion |
BAYN.F
Price: €28.25
Dividend Yield: 0.00%
Forward Dividend Yield: 8.50%
Payout Ratio: -80.27%
Dividend Per Share: 2.40 EUR
Earnings Per Share: -2.99 EUR
P/E Ratio: 28.65
Exchange: FRA
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 10585
Market Capitalization: 27.8 billion
Average Dividend Frequency: 1
Years Paying Dividends: 19